Concepedia

Ramona Dadu

RD

Statistics

Publications

59

Citations

6.4K

H-Index

37

Active since

2011

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Baylor College of Medicine

Memorial Sloan Kettering Cancer Center

Massachusetts General Hospital

The Ohio State University

Ramona Dadu is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, medicine, and thyroid cancer.

ORCID

Publications per year

2011–2025

59

Publications

59

Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group

Igor Puzanov, Adi Diab, K. Abdallah et al. · Journal for ImmunoTherapy of Cancer · 2017 · 2K citations · Full text

, , +17

Evaluation of Overall Survival in Patients With Anaplastic Thyroid Carcinoma, 2000-2019

Anastasios Maniakas, Ramona Dadu, Naifa L. Busaidy et al. · JAMA Oncology · 2020 · 385 citations · Full text

, , +16

Salvage pembrolizumab added to kinase inhibitor therapy for the treatment of anaplastic thyroid carcinoma

Priyanka Iyer, Ramona Dadu, Maria Gule-Monroe et al. · Journal for ImmunoTherapy of Cancer · 2018 · 244 citations · Full text

, , +17

Immune-Related Thyroiditis with Immune Checkpoint Inhibitors

Priyanka Iyer, Maria E. Cabanillas, Steven G. Waguespack et al. · Thyroid · 2018 · 231 citations · Full text

, , +17

Complete Surgical Resection Following Neoadjuvant Dabrafenib Plus Trametinib in <i> BRAF <sup>V600E</sup> </i> -Mutated Anaplastic Thyroid Carcinoma

Jennifer Wang, Mark Zafereo, Ramona Dadu et al. · Thyroid · 2019 · 231 citations · Full text

, , +17

1–5 of 59